Czechia, April 21 -- Czechia based Sanofi s.r.o. has secured contract from Revmatologicky ustav for Antineoplastic and immunomodulating agents Drug supplies KEVZARA 2026. The value of the contract is worth 5776238000 CZK.
Published by HT Digital Content Services with permission from Pivotal Sources....